Publications by authors named "Maria Duro"
Article Synopsis
- * A multicenter study assessed TAS-102's effectiveness and safety in 160 pretreated mCRC patients, including a significant number of elderly patients and those with other health conditions.
- * Results showed a median overall survival of 8 months and no significant age-related decrease in treatment effectiveness, indicating TAS-102 is safe and effective even for older patients.
The use and deployment of mobile devices across society is phenomenal with an increasing number of individuals using mobile devices to track their everyday health. However, there is a paucity of academic material examining this recent trend. Specifically, little is known about the use and deployment of mobile heart monitoring devices for measuring palpitations and arrhythmia.
View Article and Find Full Text PDF[Outbreak of whooping cough with a high attack rate in well-vaccinated children and adolescents].
Enferm Infecc Microbiol Clin
October 2011
Introduction: Whooping cough is a re-emerging disease. We describe the investigation of an outbreak of whooping cough and the measures of control adopted.
Methods: The event was reconstructed through a longitudinal study of incidence.
Objective: Combination therapies of fluorouracil (FU) with irinotecan (CPT-11) and docetaxel plus cisplatin have been proven to be active in metastatic gastric cancer. In this paper, we present the results of a phase III trial in which these two combinations given sequentially were compared to mitomycin C (MMC) monochemotherapy in an adjuvant setting.
Methods: 169 patients with radically resected gastric cancer were randomized to receive CPT-11 (180 mg/m2 day 1), leucovorin (100 mg/m2 days 1-2), FU (400-600 mg/m2 days 1-2, q 14; for four cycles; FOLFIRI regimen), followed by docetaxel (85 mg/m2 day 1), cisplatin (75 mg/m2 day 1, q 21; for three cycles; arm A), or MMC (8 mg/m2 days 1-2 as 2-hour infusion, q 42; for four cycles; arm B).